Health Care • Industrial Specialties
$32.92 ▲ +0.04
(+0.11%)
MKT CAP: $302.4M • VOL: 35.1K
52W L $16 52W H $36
SMTI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $103.1M | $86.7M | $65.0M |
| YoY Revenue Growth % | +19.0% | +33.4% | — |
| Gross Profit | $95.6M | $78.5M | — |
| Gross Margin % | 92.7% | 90.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $7.3M | $1.3M | -$4.2M |
| Operating Margin % | 7.1% | 1.5% | -6.5% |
| Net Income (GAAP) | $37.6M | $9.7M | $4.3M |
| EBITDA (Normalized) | $11.0M | $1.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.8M | -$23.8K | -$3.2M |
| Capital Expenditures (CapEx) | $4.6M | $205.8K | — |
| Free Cash Flow (FCF) | $2.2M | -$229.6K | -$3.2M |
| FCF Margin % | 2.1% | -0.3% | -5.0% |
| Return on Invested Capital (ROIC %) | 16.3% | 1.8% | — |
| Cash & Short-Term Equivalents | $16.6M | $15.9M | — |
| Total Debt (Short + Long Term) | $46.0M | $30.7M | — |
| Total Stockholders' Equity | $5.9M | $39.4M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SMTI.